05-533
磷酸化CaM激酶II抗体，α亚基，Thr286，克隆22B1
clone 22B1, Upstate®, from mouse
别名:
Anti-Anti-CAMKA, Anti-Anti-CaMKIINalpha, Anti-Anti-CaMKIIalpha, Anti-Anti-MRD53, Anti-Anti-MRT63
生物来源
mouse
质量水平
抗体形式
purified antibody
抗体产品类型
primary antibodies
克隆
22B1, monoclonal
种属反应性
rat
制造商/商品名称
Upstate®
技术
western blot: suitable
同位素/亚型
IgG1
NCBI登记号
UniProt登记号
运输
wet ice
靶向翻译后修饰
phosphorylation (pThr286)
基因信息
human ... CAMK2A(815)
一般描述
50kDa
免疫原
对应于大鼠CaM激酶IIα亚基残基281-294的肽；可识别苏氨酸286处磷酸化的CaM激酶II
应用
可使用这种磷酸化CaM激酶II抗体（α亚基，Thr286，克隆22B1）检测磷酸化CaM激酶II，该抗体经验证可用于WB。
生化/生理作用
磷酸化CaM激酶II α亚基
外形
形式：纯化
分析说明
已通过免疫印迹对大鼠脑微粒体蛋白的制剂进行常规评估
法律信息
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
WGK
WGK 1
Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth.
Kim, JH; Lee, JA; Song, YM; Park, CH; Hwang, SJ; Kim, YS; Kaang, BK; Son, H
Faseb Journal null
B L Patton et al.
Molecular biology of the cell, 4(2), 159-172 (1993-02-01)
We have visualized the distribution of autophosphorylated type II CaM kinase in neural tissue with the use of two complementary antibodies: a monoclonal antibody that binds to the alpha and beta subunits of the kinase only when they are autophosphorylated
Su-Ying Cui et al.
Journal of neurochemistry, 136(3), 609-619 (2015-11-13)
The Ca(2+) modulation in the dorsal raphe nucleus (DRN) plays an important role in sleep-wake regulation. Calmodulin-dependent kinase II (CaMKII) is an important signal-transducing molecule that is activated by Ca(2+) . This study investigated the effects of intracellular Ca(2+) /CaMKII
Comparative biology of cystic fibrosis animal models.
Fisher, JT; Zhang, Y; Engelhardt, JF
Methods in Molecular Biology null
Mar Cuadrado-Tejedor et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 42(2), 524-539 (2016-08-24)
The targeting of two independent but synergistic enzymatic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD). Here we report the discovery of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持